Teclozan

Teclozan is a medicinal drug used in the treatment of amoebiasis, a parasitic infection caused by Entamoeba histolytica. It is a dichloroacetamide derivative and is classified as an antiprotozoal agent.

Pharmacology

Teclozan works by inhibiting the growth of the Entamoeba histolytica parasite. It is a prodrug, which means it is metabolized in the body to produce its active form. The exact mechanism of action is not fully understood, but it is believed to interfere with the parasite's ability to synthesize proteins, thus inhibiting its growth and reproduction.

Medical uses

Teclozan is used in the treatment of intestinal amoebiasis, a condition caused by the Entamoeba histolytica parasite. This parasite can cause a range of symptoms, including diarrhea, stomach pain, and weight loss. In severe cases, it can lead to amoebic dysentery, a potentially life-threatening condition characterized by severe diarrhea, abdominal pain, and dehydration.

Side effects

Like all medications, Teclozan can cause side effects. These may include nausea, vomiting, abdominal pain, and diarrhea. In rare cases, it can cause more serious side effects, such as liver damage or allergic reactions. Patients should seek medical attention immediately if they experience any unusual or severe side effects.

See also

• Amoebiasis
• Antiprotozoal agent
• Prodrug

References

Teclozan Resources
Latest articles Most recent articles Ongoing trials	Wikipedia